U.S. Markets closed

Is Shenghua Lande Scitech Limited (HKG:8106) Investing Your Capital Efficiently?

Simply Wall St

Today we are going to look at Shenghua Lande Scitech Limited (HKG:8106) to see whether it might be an attractive investment prospect. Specifically, we'll consider its Return On Capital Employed (ROCE), since that will give us an insight into how efficiently the business can generate profits from the capital it requires.

First, we'll go over how we calculate ROCE. Second, we'll look at its ROCE compared to similar companies. Finally, we'll look at how its current liabilities affect its ROCE.

Understanding Return On Capital Employed (ROCE)

ROCE is a metric for evaluating how much pre-tax income (in percentage terms) a company earns on the capital invested in its business. Generally speaking a higher ROCE is better. Overall, it is a valuable metric that has its flaws. Renowned investment researcher Michael Mauboussin has suggested that a high ROCE can indicate that 'one dollar invested in the company generates value of more than one dollar'.

So, How Do We Calculate ROCE?

Analysts use this formula to calculate return on capital employed:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

Or for Shenghua Lande Scitech:

0.036 = CN¥3.6m ÷ (CN¥137m - CN¥35m) (Based on the trailing twelve months to September 2019.)

So, Shenghua Lande Scitech has an ROCE of 3.6%.

See our latest analysis for Shenghua Lande Scitech

Is Shenghua Lande Scitech's ROCE Good?

ROCE is commonly used for comparing the performance of similar businesses. Using our data, Shenghua Lande Scitech's ROCE appears to be significantly below the 9.9% average in the Electronic industry. This performance is not ideal, as it suggests the company may not be deploying its capital as effectively as some competitors. Putting aside Shenghua Lande Scitech's performance relative to its industry, its ROCE in absolute terms is poor - considering the risk of owning stocks compared to government bonds. There are potentially more appealing investments elsewhere.

Shenghua Lande Scitech reported an ROCE of 3.6% -- better than 3 years ago, when the company didn't make a profit. This makes us wonder if the company is improving. You can see in the image below how Shenghua Lande Scitech's ROCE compares to its industry. Click to see more on past growth.

SEHK:8106 Past Revenue and Net Income, January 25th 2020

When considering this metric, keep in mind that it is backwards looking, and not necessarily predictive. ROCE can be misleading for companies in cyclical industries, with returns looking impressive during the boom times, but very weak during the busts. ROCE is, after all, simply a snap shot of a single year. If Shenghua Lande Scitech is cyclical, it could make sense to check out this free graph of past earnings, revenue and cash flow.

How Shenghua Lande Scitech's Current Liabilities Impact Its ROCE

Current liabilities include invoices, such as supplier payments, short-term debt, or a tax bill, that need to be paid within 12 months. Due to the way the ROCE equation works, having large bills due in the near term can make it look as though a company has less capital employed, and thus a higher ROCE than usual. To check the impact of this, we calculate if a company has high current liabilities relative to its total assets.

Shenghua Lande Scitech has total assets of CN¥137m and current liabilities of CN¥35m. Therefore its current liabilities are equivalent to approximately 26% of its total assets. With a very reasonable level of current liabilities, so the impact on ROCE is fairly minimal.

Our Take On Shenghua Lande Scitech's ROCE

While that is good to see, Shenghua Lande Scitech has a low ROCE and does not look attractive in this analysis. Of course, you might find a fantastic investment by looking at a few good candidates. So take a peek at this free list of companies with modest (or no) debt, trading on a P/E below 20.

If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: insiders have been buying them).

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.